Emerald Advisers, LLC Atri Cure, Inc. Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 389,836 shares of ATRC stock, worth $14.4 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

389,836

Previous 351,415 10.93%

Holding current value

$14.4 Million

Previous $8 Million 36.62%

% of portfolio

0.45%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$20.34 - $29.5 $781,483 - $1.13 Million	38,421 Added 10.93%	389,836 $10.9 Million
Q2 2024 Aug 06, 2024	SELL	$19.86 - $29.09 $1.98 Million - $2.9 Million	-99,843 Reduced 22.13%	351,415 $8 Million
Q1 2024 May 08, 2024	BUY	$28.21 - $37.78 $140,429 - $188,068	4,978 Added 1.12%	451,258 $13.7 Million
Q4 2023 Feb 05, 2024	SELL	$32.99 - $43.25 $1.74 Million - $2.28 Million	-52,692 Reduced 10.56%	446,280 $15.9 Million
Q3 2023 Oct 26, 2023	BUY	$41.12 - $57.73 $123 - $173	3 Added 0.0%	498,972 $21.9 Million
Q2 2023 Jul 25, 2023	SELL	$40.44 - $49.6 $359,471 - $440,894	-8,889 Reduced 1.75%	498,969 $24.6 Million
Q1 2023 May 04, 2023	SELL	$35.87 - $47.22 $332,120 - $437,209	-9,259 Reduced 1.79%	507,858 $21.1 Million
Q4 2022 Feb 03, 2023	BUY	$33.48 - $47.45 $2.96 Million - $4.2 Million	88,486 Added 20.64%	517,117 $22.9 Million
Q3 2022 Oct 25, 2022	BUY	$38.25 - $52.62 $7,650 - $10,524	200 Added 0.05%	428,631 $16.8 Million
Q2 2022 Jul 29, 2022	SELL	$35.1 - $66.01 $278,974 - $524,647	-7,948 Reduced 1.82%	428,431 $17.5 Million
Q1 2022 Apr 29, 2022	BUY	$57.43 - $71.39 $2.34 Million - $2.91 Million	40,816 Added 10.32%	436,379 $28.7 Million
Q4 2021 Feb 02, 2022	SELL	$63.4 - $87.14 $534,208 - $734,241	-8,426 Reduced 2.09%	395,563 $27.5 Million
Q3 2021 Oct 28, 2021	SELL	$69.28 - $84.46 $6.45 Million - $7.86 Million	-93,040 Reduced 18.72%	403,989 $28.1 Million
Q2 2021 Jul 29, 2021	SELL	$64.13 - $80.18 $274,604 - $343,330	-4,282 Reduced 0.85%	497,029 $39.4 Million
Q1 2021 Apr 29, 2021	SELL	$53.79 - $66.98 $1.87 Million - $2.33 Million	-34,788 Reduced 6.49%	501,311 $32.8 Million
Q4 2020 Jan 29, 2021	BUY	$34.56 - $57.55 $1.22 Million - $2.03 Million	35,251 Added 7.04%	536,099 $29.8 Million
Q3 2020 Oct 28, 2020	SELL	$38.36 - $46.91 $821,863 - $1.01 Million	-21,425 Reduced 4.1%	500,848 $20 Million
Q2 2020 Jul 28, 2020	BUY	$31.78 - $51.19 $3.04 Million - $4.9 Million	95,661 Added 22.42%	522,273 $23.5 Million
Q1 2020 Apr 30, 2020	SELL	$24.49 - $43.84 $46,702 - $83,602	-1,907 Reduced 0.45%	426,612 $14.3 Million
Q4 2019 Jan 29, 2020	SELL	$24.06 - $32.51 $276,497 - $373,604	-11,492 Reduced 2.61%	428,519 $13.9 Million
Q3 2019 Oct 31, 2019	SELL	$23.81 - $32.52 $790,944 - $1.08 Million	-33,219 Reduced 7.02%	440,011 $11 Million
Q2 2019 Jul 31, 2019	SELL	$26.85 - $30.74 $123,510 - $141,404	-4,600 Reduced 0.96%	473,230 $14.1 Million
Q1 2019 May 01, 2019	BUY	$26.38 - $33.34 $282,793 - $357,404	10,720 Added 2.29%	477,830 $12.8 Million
Q4 2018 Jan 30, 2019	SELL	$26.66 - $34.85 $308,882 - $403,772	-11,586 Reduced 2.42%	467,110 $14.3 Million
Q3 2018 Oct 31, 2018	SELL	$27.62 - $35.58 $549,361 - $707,686	-19,890 Reduced 3.99%	478,696 $16.8 Million
Q2 2018 Jul 31, 2018	SELL	$19.65 - $30.28 $106,306 - $163,814	-5,410 Reduced 1.07%	498,586 $13.5 Million
Q1 2018 Apr 26, 2018	SELL	$15.05 - $21.03 $743,695 - $1.04 Million	-49,415 Reduced 8.93%	503,996 $10.3 Million
Q4 2017 Feb 05, 2018	SELL	$17.69 - $23.44 $128,960 - $170,877	-7,290 Reduced 1.3%	553,411 $10.1 Million
Q3 2017 Oct 30, 2017	BUY	$20.0 - $24.23 $11.2 Million - $13.6 Million	560,701	560,701 $12.5 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.72B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Atri Cure, Inc. Transaction History